123 related articles for article (PubMed ID: 1959785)
1. Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients.
Strang P; Stendahl U; Bergström R; Frankendal B; Tribukait B
Gynecol Oncol; 1991 Oct; 43(1):3-8. PubMed ID: 1959785
[TBL] [Abstract][Full Text] [Related]
2. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
[TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid ploidy and S-phase fraction are not significant prognostic factors for patients with cervical cancer.
Jelen I; Valente PT; Gautreaux L; Clark GM
Am J Obstet Gynecol; 1994 Dec; 171(6):1511-6; discussion 1516-8. PubMed ID: 7802060
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
[TBL] [Abstract][Full Text] [Related]
5. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
[TBL] [Abstract][Full Text] [Related]
8. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
[TBL] [Abstract][Full Text] [Related]
9. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
12. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
Strang P; Stendahl U; Tribukait B
Ann N Y Acad Sci; 1993 Mar; 677():354-63. PubMed ID: 8494220
[No Abstract] [Full Text] [Related]
14. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
15. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
Strang P; Eklund G; Stendahl U; Frankendal B
Anticancer Res; 1987; 7(4B):807-10. PubMed ID: 3674766
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
17. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
[TBL] [Abstract][Full Text] [Related]
18. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
Green RW; Engblom S; Baldetorp B; Hartman L; Måsbäck A; Bjurberg M
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1064-73. PubMed ID: 26123703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
